Cargando…

Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study

BACKGROUND: In patients with angina undergoing invasive management, no obstructive coronary artery disease (NOCAD) is a common finding, and angina may persist following percutaneous coronary intervention (PCI). Coronary microvascular dysfunction may be relevant. We aimed to assess the proportion of...

Descripción completa

Detalles Bibliográficos
Autores principales: Corcoran, David, Young, Robin, Adlam, David, McConnachie, Alex, Mangion, Kenneth, Ripley, David, Cairns, David, Brown, Julia, Bucciarelli-Ducci, Chiara, Baumbach, Andreas, Kharbanda, Rajesh, Oldroyd, Keith G., McCann, Gerry P., Greenwood, John P., Berry, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008494/
https://www.ncbi.nlm.nih.gov/pubmed/29716756
http://dx.doi.org/10.1016/j.ijcard.2018.04.061
_version_ 1783333187288563712
author Corcoran, David
Young, Robin
Adlam, David
McConnachie, Alex
Mangion, Kenneth
Ripley, David
Cairns, David
Brown, Julia
Bucciarelli-Ducci, Chiara
Baumbach, Andreas
Kharbanda, Rajesh
Oldroyd, Keith G.
McCann, Gerry P.
Greenwood, John P.
Berry, Colin
author_facet Corcoran, David
Young, Robin
Adlam, David
McConnachie, Alex
Mangion, Kenneth
Ripley, David
Cairns, David
Brown, Julia
Bucciarelli-Ducci, Chiara
Baumbach, Andreas
Kharbanda, Rajesh
Oldroyd, Keith G.
McCann, Gerry P.
Greenwood, John P.
Berry, Colin
author_sort Corcoran, David
collection PubMed
description BACKGROUND: In patients with angina undergoing invasive management, no obstructive coronary artery disease (NOCAD) is a common finding, and angina may persist following percutaneous coronary intervention (PCI). Coronary microvascular dysfunction may be relevant. We aimed to assess the proportion of patients presenting with suspected CAD who had coronary microvascular dysfunction. METHODS: Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease 2 (CE-MARC 2) was a prospective multicenter randomised controlled trial of functional imaging versus guideline-based management in patients with suspected CAD. Invasive coronary angiography was protocol-directed. Fractional flow reserve (FFR) and parameters of microvascular function (coronary flow reserve (CFR), index of microcirculatory resistance (IMR), resistance reserve ratio (RRR)) were measured in major epicardial coronary arteries with ≥40–≤90% diameter stenosis. An FFR value ≤0.80 indicated the presence of obstructive CAD. RESULTS: 267/1202 (22.2%) patients underwent angiography and 81 (30%) patients had FFR measured. 63 (78%) of these patients had microvascular function assessed in 85 arteries (mean age 58.5 ± 8.2 years; 47 (75%) male). 25/63 (40%) patients had NOCAD, and of these, 17 (68%) had an abnormality ≥1 parameter of microvascular function (abnormal IMR (≥25), abnormal CFR (<2.0), and abnormal RRR (<2.0) occurred in 10 (40%), 12 (48%), and 11 (44%), respectively). 38/63 (60%) patients had obstructive epicardial CAD. Of these patients, 15/38 (39%), 20/38 (53%), and 12/38 (32%) had an abnormal IMR, CFR and RRR, respectively. CONCLUSIONS: Coronary microvascular dysfunction is common in patients with angina. Invasive assessment of microvascular function may be informative and relevant for decision-making in patients with both NOCAD and obstructive epicardial CAD. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01664858
format Online
Article
Text
id pubmed-6008494
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60084942018-09-01 Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study Corcoran, David Young, Robin Adlam, David McConnachie, Alex Mangion, Kenneth Ripley, David Cairns, David Brown, Julia Bucciarelli-Ducci, Chiara Baumbach, Andreas Kharbanda, Rajesh Oldroyd, Keith G. McCann, Gerry P. Greenwood, John P. Berry, Colin Int J Cardiol Article BACKGROUND: In patients with angina undergoing invasive management, no obstructive coronary artery disease (NOCAD) is a common finding, and angina may persist following percutaneous coronary intervention (PCI). Coronary microvascular dysfunction may be relevant. We aimed to assess the proportion of patients presenting with suspected CAD who had coronary microvascular dysfunction. METHODS: Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease 2 (CE-MARC 2) was a prospective multicenter randomised controlled trial of functional imaging versus guideline-based management in patients with suspected CAD. Invasive coronary angiography was protocol-directed. Fractional flow reserve (FFR) and parameters of microvascular function (coronary flow reserve (CFR), index of microcirculatory resistance (IMR), resistance reserve ratio (RRR)) were measured in major epicardial coronary arteries with ≥40–≤90% diameter stenosis. An FFR value ≤0.80 indicated the presence of obstructive CAD. RESULTS: 267/1202 (22.2%) patients underwent angiography and 81 (30%) patients had FFR measured. 63 (78%) of these patients had microvascular function assessed in 85 arteries (mean age 58.5 ± 8.2 years; 47 (75%) male). 25/63 (40%) patients had NOCAD, and of these, 17 (68%) had an abnormality ≥1 parameter of microvascular function (abnormal IMR (≥25), abnormal CFR (<2.0), and abnormal RRR (<2.0) occurred in 10 (40%), 12 (48%), and 11 (44%), respectively). 38/63 (60%) patients had obstructive epicardial CAD. Of these patients, 15/38 (39%), 20/38 (53%), and 12/38 (32%) had an abnormal IMR, CFR and RRR, respectively. CONCLUSIONS: Coronary microvascular dysfunction is common in patients with angina. Invasive assessment of microvascular function may be informative and relevant for decision-making in patients with both NOCAD and obstructive epicardial CAD. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01664858 Elsevier 2018-09-01 /pmc/articles/PMC6008494/ /pubmed/29716756 http://dx.doi.org/10.1016/j.ijcard.2018.04.061 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Corcoran, David
Young, Robin
Adlam, David
McConnachie, Alex
Mangion, Kenneth
Ripley, David
Cairns, David
Brown, Julia
Bucciarelli-Ducci, Chiara
Baumbach, Andreas
Kharbanda, Rajesh
Oldroyd, Keith G.
McCann, Gerry P.
Greenwood, John P.
Berry, Colin
Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study
title Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study
title_full Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study
title_fullStr Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study
title_full_unstemmed Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study
title_short Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study
title_sort coronary microvascular dysfunction in patients with stable coronary artery disease: the ce-marc 2 coronary physiology sub-study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008494/
https://www.ncbi.nlm.nih.gov/pubmed/29716756
http://dx.doi.org/10.1016/j.ijcard.2018.04.061
work_keys_str_mv AT corcorandavid coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT youngrobin coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT adlamdavid coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT mcconnachiealex coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT mangionkenneth coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT ripleydavid coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT cairnsdavid coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT brownjulia coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT bucciarelliduccichiara coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT baumbachandreas coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT kharbandarajesh coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT oldroydkeithg coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT mccanngerryp coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT greenwoodjohnp coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy
AT berrycolin coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy